跳至主要内容
临床试验/EUCTR2007-006026-10-IT
EUCTR2007-006026-10-IT进行中(未招募)不适用

PREOPERATIVE ENDOCRINE TREATMENT WITH LETROZOLE ± TRIPTORELIN IN PATIENTS WITH ER AND PgR POSITIVE LOCALLY ADVANCED BREAST CANCER

ISTITUTO EUROPEO DI ONCOLOGIA0 个研究点开始时间: 2008年2月21日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • ? Patients with histologically proven, locally advanced, primary breast cancer (cT2-T4b, N0-2, M0) ? Endocrine responsive primary breast cancer (ER and PgR #8805; 50%) ? Absence of HER2/neu overexpression or amplification ? Absence of distant metastasis
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • ?Presence of HER2/neu overexpression or amplification
  • ?Patients with other non-malignant uncontrolled systemic diseases that would preclude trial entry in the opinion of the investigator.
  • ?Patients with distant metastatic disease
  • ?Previous adjuvant and/or neoadjuvant treatment for breast cancer
  • ?Other co-existing malignancies or malignancies diagnosed within the last 5 years with the exception of basal cell carcinoma or cervical cancer in situ.

研究者

相似试验